|
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016 open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15 |
Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter
Copyright Infringement Claims
Indexing Partner
|
Published Paper Details
|
|
| Paper Title: | CASE STUDY: SCHIZOPHRENIA WITH ANTIPSYCHOTICS INDUCED PSEUDO PARKINSONISM |
| Authors Name: | MUHAMMED ALFAS M , MOHAMMED AZEEL , LAKSHMI C , CHAITANYA K , Dr. S CHITHRAHASINI |
| Unique Id: | IJSDR2403016 |
| Published In: | Volume 9 Issue 3, March-2024 |
| Abstract: | Schizophrenia is a complex, chronic mental health disorder and serious mental illness that affects how a person thinks, feels, and behaves. such patients lose touch with reality which can affect their family and friends. Also called as altered perception syndrome characterized by positive, negative, and cognitive symptoms, caused by chemical imbalances and other changes in the brain. It is treated with antipsychotic medication and psychotherapeutic approaches. The adverse effects of schizophrenia medication in several organ systems, In the Central Nervous System it induces Dystonia, Akathisia, Pseudo parkinsonism, tardive dyskinesia, akinesia, and all antipsychotics increase the risk of seizures. In this case, the patient has almost 14 years of anti-psychotic medications are risperidone, chlorpromazine, diazepam, and trihexyphenidyl, he maintained well with the medication with regular follow-up but in 4 months before he left the trihexyphenidyl medication without any knowledge about its benefits and importance of the medication. It will lead to dopamine deficiency with an increased level of acetylcholine leads to extrapyramidal symptoms such as Pseudo parkinsonism. It could be due to medication adherence and compliance with medication, knowledge, and carefulness of patients regarding their medication, and also physician or health provider's knowledge, skill, and sincerity may effects. The patient's tendency to increase and decrease the medication on one’s own is detrimental to the health and lifestyle. Eliminating conditions like these is essential, otherwise it will increase the economic burden on the community and affect the patient's quality of life. avoiding such incidents also required the intensive support of clinical and community pharmacists. Their drug monitoring and counseling help to eliminate medication-related adverse drug reactions. |
| Keywords: | Schizophrenia, antipsychotics, FGAs, SGAs, extrapyramidal symptoms(EPS), Pseudo parkinsonism |
| Cite Article: | "CASE STUDY: SCHIZOPHRENIA WITH ANTIPSYCHOTICS INDUCED PSEUDO PARKINSONISM", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.9, Issue 3, page no.103 - 107, March-2024, Available :http://www.ijsdr.org/papers/IJSDR2403016.pdf |
| Downloads: | 000337363 |
| Publication Details: | Published Paper ID: IJSDR2403016 Registration ID:210186 Published In: Volume 9 Issue 3, March-2024 DOI (Digital Object Identifier): Page No: 103 - 107 Publisher: IJSDR | www.ijsdr.org ISSN Number: 2455-2631 |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijsdr.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
Track Paper
Important Links
Conference Proposal
ISSN
 |
 |
DOI (A digital object identifier)
  Providing A digital object identifier by DOI How to GET DOI and Hard Copy Related |
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
 |
 |
 |
Social Media
Indexing Partner |
|||
| Copyright © 2024 - All Rights Reserved - IJSDR | |||
Facebook Twitter Instagram LinkedIn